TROV : Summary for TrovaGene, Inc. - Yahoo Finance

U.S. Markets close in 56 mins.

TrovaGene, Inc. (TROV)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.50-0.00 (-0.00%)
As of 3:03 PM EST. Market open.
People also watch:
SGYPIDRABIOCTRVNLBIO
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close2.50
Open2.50
Bid2.45 x 7200
Ask2.50 x 3900
Day's Range2.45 - 2.65
52 Week Range2.45 - 6.93
Volume154,798
Avg. Volume254,221
Market Cap76.54M
Beta0.76
PE Ratio (TTM)-1.92
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • TrovaGene Inks Contract with Boreal Genomics, Stock Down
    Zacks5 days ago

    TrovaGene Inks Contract with Boreal Genomics, Stock Down

    TrovaGene Inc. (TROV), a molecular diagnostic company, recently announced the signing of a long-term Supply and Distribution Agreement with Boreal Genomics.

  • PR Newswire6 days ago

    Trovagene and Boreal Genomics Announce Strategic Partnership

    SAN DIEGO, Nov. 30, 2016 /PRNewswire/ -- Trovagene, Inc. (TROV), a developer of circulating tumor DNA (ctDNA) molecular diagnostics, today announced it has entered into a long-term Supply and Distribution Agreement with Boreal Genomics, merging their respective technologies to co-develop urine and blood ctDNA assay kits.

  • Zacks7 days ago

    TrovaGene (TROV) Precision Cancer Monitoring Data Positive

    TrovaGene Inc. (TROV) recently announced encouraging data pertaining to its Precision Cancer Monitoring (PCM) technology for both urine and plasma EGFR mutation testing.